# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-23-092219
Filing Date
2023-08-16
Accepted
2023-08-16 07:31:25
Documents
30
Period of Report
2023-08-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2323901d1_8k.htm iXBRL | 8-K | 35637
2 | EXHIBIT 99.1 | tm2323901d1_ex99-1.htm | EX-99.1 | 15818
3 | EXHIBIT 99.2 | tm2323901d1_ex99-2.htm | EX-99.2 | 18857
7 | GRAPHIC | tm2323901d1_ex99-2img001.jpg | GRAPHIC | 115990
8 | GRAPHIC | tm2323901d1_ex99-2img002.jpg | GRAPHIC | 302426
9 | GRAPHIC | tm2323901d1_ex99-2img003.jpg | GRAPHIC | 142693
10 | GRAPHIC | tm2323901d1_ex99-2img004.jpg | GRAPHIC | 149513
11 | GRAPHIC | tm2323901d1_ex99-2img005.jpg | GRAPHIC | 110412
12 | GRAPHIC | tm2323901d1_ex99-2img006.jpg | GRAPHIC | 162305
13 | GRAPHIC | tm2323901d1_ex99-2img007.jpg | GRAPHIC | 179640
14 | GRAPHIC | tm2323901d1_ex99-2img008.jpg | GRAPHIC | 178619
15 | GRAPHIC | tm2323901d1_ex99-2img009.jpg | GRAPHIC | 191504
16 | GRAPHIC | tm2323901d1_ex99-2img010.jpg | GRAPHIC | 163173
17 | GRAPHIC | tm2323901d1_ex99-2img011.jpg | GRAPHIC | 138170
18 | GRAPHIC | tm2323901d1_ex99-2img012.jpg | GRAPHIC | 196773
19 | GRAPHIC | tm2323901d1_ex99-2img013.jpg | GRAPHIC | 113859
20 | GRAPHIC | tm2323901d1_ex99-2img014.jpg | GRAPHIC | 138435
21 | GRAPHIC | tm2323901d1_ex99-2img015.jpg | GRAPHIC | 38581
22 | GRAPHIC | image_001.jpg | GRAPHIC | 2341
| Complete submission text file | 0001104659-23-092219.txt |  | 3462571

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | eyen-20230815.xsd | EX-101.SCH | 3015
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | eyen-20230815_lab.xml | EX-101.LAB | 34240
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | eyen-20230815_pre.xml | EX-101.PRE | 22359
24 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2323901d1_8k_htm.xml | XML | 3397

Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 231176491
SIC: 2834 Pharmaceutical Preparations